• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者室旁下丘脑核中胰高血糖素样肽-1 受体水平升高。

Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients.

机构信息

Human Brain Tissue Bank, Semmelweis University, 1094 Budapest, Hungary.

Human Brain Tissue Bank and Microdissection Laboratory, Semmelweis University, 1094 Budapest, Hungary.

出版信息

Int J Mol Sci. 2022 Dec 15;23(24):15945. doi: 10.3390/ijms232415945.

DOI:10.3390/ijms232415945
PMID:36555587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9781792/
Abstract

Glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists have been approved for the treatment of type 2 diabetes mellitus (T2DM); however, the brain actions of these drugs are not properly established. We used post mortem microdissected human hypothalamic samples for RT-qPCR and Western blotting. For in situ hybridization histochemistry and immunolabelling, parallel cryosections were prepared from the hypothalamus. We developed in situ hybridization probes for human GLP-1R and oxytocin. In addition, GLP-1 and oxytocin were visualized by immunohistochemistry. Radioactive in situ hybridization histochemistry revealed abundant GLP-1R labelling in the human paraventricular hypothalamic nucleus (PVN), particularly in its magnocellular subdivision (PVNmc). Quantitative analysis of the mRNA signal demonstrated increased GLP-1R expression in the PVNmc in post mortem hypothalamic samples from T2DM subjects as compared to controls, while there was no difference in the expression level of GLP-1R in the other subdivisions of the PVN, the hypothalamic dorsomedial and infundibular nuclei. Our results in the PVN were confirmed by RT-qPCR. Furthermore, we demonstrated by Western blot technique that the GLP-1R protein level was also elevated in the PVN of T2DM patients. GLP-1 fibre terminals were also observed in the PVNmc closely apposing oxytocin neurons using immunohistochemistry. The data suggest that GLP-1 activates GLP-1Rs in the PVNmc and that GLP-1R is elevated in T2DM patients, which may be related to the dysregulation of feeding behaviour and glucose homeostasis in T2DM.

摘要

胰高血糖素样肽-1(GLP-1)受体(GLP-1R)激动剂已被批准用于治疗 2 型糖尿病(T2DM);然而,这些药物在大脑中的作用尚未得到充分证实。我们使用死后微解剖的人下丘脑样本进行 RT-qPCR 和 Western blot 分析。为了进行原位杂交组织化学和免疫标记,我们从下丘脑制备了平行的冷冻切片。我们开发了用于人 GLP-1R 和催产素的原位杂交探针。此外,通过免疫组织化学显示 GLP-1 和催产素。放射性原位杂交组织化学显示 GLP-1R 在人室旁下丘脑核(PVN)中大量标记,特别是在其大细胞亚区(PVNmc)中。定量分析 mRNA 信号表明,与对照组相比,T2DM 患者死后下丘脑样本中 PVNmc 中的 GLP-1R 表达增加,而 PVN 的其他亚区、下丘脑背内侧核和漏斗核中 GLP-1R 的表达水平没有差异。我们在 PVN 中的结果通过 RT-qPCR 得到了证实。此外,我们还通过 Western blot 技术证明,T2DM 患者的 PVN 中 GLP-1R 蛋白水平也升高了。使用免疫组织化学还观察到 GLP-1 纤维末端紧密毗邻催产素神经元存在于 PVNmc 中。这些数据表明,GLP-1 在 PVNmc 中激活 GLP-1R,并且在 T2DM 患者中 GLP-1R 升高,这可能与 T2DM 中摄食行为和葡萄糖稳态的失调有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/c8b024fa5245/ijms-23-15945-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/68ff8e2f9f34/ijms-23-15945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/02d18a2817ce/ijms-23-15945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/183073c94e5c/ijms-23-15945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/3b54c90c5afa/ijms-23-15945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/5e1fe66a9ac1/ijms-23-15945-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/c8b024fa5245/ijms-23-15945-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/68ff8e2f9f34/ijms-23-15945-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/02d18a2817ce/ijms-23-15945-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/183073c94e5c/ijms-23-15945-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/3b54c90c5afa/ijms-23-15945-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/5e1fe66a9ac1/ijms-23-15945-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8156/9781792/c8b024fa5245/ijms-23-15945-g006.jpg

相似文献

1
Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients.2 型糖尿病患者室旁下丘脑核中胰高血糖素样肽-1 受体水平升高。
Int J Mol Sci. 2022 Dec 15;23(24):15945. doi: 10.3390/ijms232415945.
2
Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients.2型糖尿病患者下丘脑胰高血糖素样肽-1受体表达降低。
J Clin Endocrinol Metab. 2016 May;101(5):2122-9. doi: 10.1210/jc.2015-3291. Epub 2015 Dec 16.
3
Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.胰高血糖素样肽-1的中枢给药激活大鼠下丘脑神经内分泌神经元。
Endocrinology. 1997 Oct;138(10):4445-55. doi: 10.1210/endo.138.10.5270.
4
GLP-1 Receptor Signaling Has Different Effects on the Perikarya and Axons of the Hypophysiotropic Thyrotropin-Releasing Hormone Synthesizing Neurons in Male Mice.GLP-1 受体信号对雄性小鼠下丘脑促甲状腺素释放激素合成神经元的胞体和轴突有不同的影响。
Thyroid. 2024 Feb;34(2):252-260. doi: 10.1089/thy.2023.0284. Epub 2024 Jan 9.
5
Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.内源性 GLP-1 通过作用于室旁核来抑制摄食:来自孤束核的投射以及促肾上腺皮质激素释放激素、nesfatin-1 和催产素神经元的激活。
Biochem Biophys Res Commun. 2014 Aug 22;451(2):276-81. doi: 10.1016/j.bbrc.2014.07.116. Epub 2014 Aug 1.
6
Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.胰高血糖素样肽-1(7-36)酰胺(GLP-1)神经末梢密集支配下丘脑室旁核中的促肾上腺皮质激素释放激素神经元。
Brain Res. 2003 Sep 26;985(2):163-8. doi: 10.1016/s0006-8993(03)03117-2.
7
The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.下丘脑胰高血糖素样肽-1受体对小鼠能量平衡和葡萄糖稳态的调节是充分但非必要的。
Diabetes. 2017 Feb;66(2):372-384. doi: 10.2337/db16-1102. Epub 2016 Dec 1.
8
Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1(7-36)amide on vasopressin and oxytocin release.胰高血糖素样肽-1(GLP-1)受体、血管加压素和催产素mRNA在大鼠下丘脑视上核和室旁核神经元中的共表达:GLP-1(7-36)酰胺对血管加压素和催产素释放的影响
J Neurochem. 1999 Jan;72(1):10-6. doi: 10.1046/j.1471-4159.1999.0720010.x.
9
Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei.胰高血糖素样肽-1免疫反应性在下丘脑室旁核和视上核中的分布。
J Chem Neuroanat. 2008 Dec;36(3-4):144-9. doi: 10.1016/j.jchemneu.2008.07.009. Epub 2008 Aug 19.
10
Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization.利用新型抗体和原位杂交技术研究雄性小鼠大脑中的胰高血糖素样肽-1 受体。
Endocrinology. 2018 Feb 1;159(2):665-675. doi: 10.1210/en.2017-00812.

本文引用的文献

1
Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders.二甲双胍在大脑中的作用:二甲双胍治疗相关神经障碍的新视角。
Int J Mol Sci. 2022 Jul 27;23(15):8281. doi: 10.3390/ijms23158281.
2
Transcriptome Profiling of the Dorsomedial Prefrontal Cortex in Suicide Victims.自杀未遂者背内侧前额叶皮质的转录组谱分析。
Int J Mol Sci. 2022 Jun 25;23(13):7067. doi: 10.3390/ijms23137067.
3
New developments in the prospects for GLP-1 therapy.胰高血糖素样肽-1(GLP-1)疗法的新进展。
Br J Pharmacol. 2022 Feb;179(4):489-491. doi: 10.1111/bph.15788.
4
Peptide-YY/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.肽 YY/胰高血糖素样肽-1 联合治疗肥胖型糖尿病小鼠可改善胰岛素敏感性,与恢复的胰腺β细胞功能以及离散的下丘脑和脑干神经元回路的协同激活有关。
Mol Metab. 2022 Jan;55:101392. doi: 10.1016/j.molmet.2021.101392. Epub 2021 Nov 12.
5
Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics.脑内胰高血糖素样肽-1(GLP-1)信号:从神经回路和代谢到治疗。
Br J Pharmacol. 2022 Feb;179(4):600-624. doi: 10.1111/bph.15682. Epub 2021 Nov 4.
6
Central and peripheral GLP-1 systems independently suppress eating.中枢和外周 GLP-1 系统独立地抑制摄食。
Nat Metab. 2021 Feb;3(2):258-273. doi: 10.1038/s42255-021-00344-4. Epub 2021 Feb 15.
7
Metabolic Messengers: glucagon-like peptide 1.代谢信使:胰高血糖素样肽 1。
Nat Metab. 2021 Feb;3(2):142-148. doi: 10.1038/s42255-020-00327-x. Epub 2021 Jan 11.
8
Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain.胰高血糖素样肽-1 受体 (GLP-1R) 在大鼠脑内的分布和超微结构定位。
Brain Struct Funct. 2021 Jan;226(1):225-245. doi: 10.1007/s00429-020-02189-1. Epub 2020 Dec 20.
9
Leptin suppresses development of GLP-1 inputs to the paraventricular nucleus of the hypothalamus.瘦素抑制 GLP-1 传入下丘脑室旁核的发育。
Elife. 2020 Nov 18;9:e59857. doi: 10.7554/eLife.59857.
10
Semaglutide lowers body weight in rodents via distributed neural pathways.司美格鲁肽通过分布式神经通路降低啮齿动物的体重。
JCI Insight. 2020 Mar 26;5(6):133429. doi: 10.1172/jci.insight.133429.